Recent business and finance press releases & news

Looking for the latest news on the products and services you patronize? Presswire is your go-to website. Presswire is the leading online news and press release distribution service. Used by thousands of organizations of every size to get better visibility, improve their ranks on the search engines, drive traffic to their website, and deliver the latest news to their respective target audiences. Presswire's press release distribution services go to various media outlets in our media contacts database, keeping everyone in-the-know informed. Do you have a news story to feature? Send and create your stories or product and service news to Presswire, but filling out the form here.

CANADA CARBON INC. ANNOUNCES CHANGE OF CHIEF FINANCIAL OFFICER

 

[PRESSWIRE] 2 May, 2022, Toronto, ON, Canada – (TSX-V: CCB) (OTC: BRUZF) (Frankfurt: U7N1). Canada Carbon Inc. (the "Company") is pleased to announce the appointment of Remantra Sheopaul as Chief Financial Officer of the Company, replacing Olga Nikitovic, effective immediately. The Company thanks Ms. Nikitovic for her tenure as Chief Financial Officer and Chief Executive Officer through December 2021 and for continuing in a consulting capacity, on accounting and financial matters, through April 2022.

CANADA CARBON ANNOUNCES CLOSING OF PRIVATE PLACEMENT TRANCHE

 

 

[PRESSWIRE] Toronto, ON, Canada - April 28, 2022 -- Further to its press release dated April 12, 2022, Canada Carbon Inc. (the "Company") (TSX-V: CCB) is pleased to announce the closing of the first tranche of a non-brokered private placement of 11,640,000 units (each, a “Unit”) at a price of $0.075 per Unit (the “Issue Price”) for aggregate gross proceeds of $872,900 (the “Offering”). Each Unit is comprised of one common share (each, a “Common Share”) in the capital of the Company and one common share purchase warrant (each, a “Warrant”).

ProMIS Neurosciences Reports New Milestones in Potential Therapeutic Approaches for Amyotrophic Lateral Sclerosis (ALS)

 

[PRESSWIRE] TORONTO, Ontario and CAMBRIDGE, MA —April 28, 2022 — ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of potential therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today new milestones in potential therapeutic approaches for ALS.

Fobi Launches Verified Digital and First of its Kind App-less Investor Relations Platform Leveraging Fobi’s AI, Big Data and Mobile Wallet Technology

 

Investor Pass utilizes Fobi’s Wallet pass platform for IR communications to unify all the touchpoints that companies have with their investors to deliver personalized information in real-time to their shareholders.

ProMIS appoints experienced industry veteran Larry Altstiel as Chief Medical Officer

 

[PRESSWIRE] TORONTO, Ontario and CAMBRIDGE, Mass. April 19, 2022 - ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting misfolded proteins such as toxic oligomers implicated in the development of neurodegenerative diseases, announced today that it has appointed Larry Altstiel M.D. Ph.D., as Chief Medical Officer.

Skyharbour’s Partner Company Basin Uranium Corp. Announces Completion and Mobilization of Exploration Crews to Mann Lake Uranium Project

 

[PRESSWIRE] 18.04.22 -- Vancouver, BC - Skyharbour Resources Ltd.’s (TSX-V: SYH) (OTCQB: SYHBF) (Frankfurt: SC1P) (the “Company”) partner company, Basin Uranium Corp. (“Basin Uranium”), is pleased to announce its exploration plan for its Phase 1 program at the Mann Lake uranium project in Saskatchewan’s prolific Athabasca Basin.

1

Zero Carbon Capital closes first £10m of £30m fund for pre-seed & seed decarbonisation investments

 

[PRESSWIRE] London, UK - 14.04.22 -- Zero Carbon Capital Ltd has today announced the first close of the new Zero Carbon Capital 2022 LP fund. They have raised £10m toward a target of £30m to invest in extraordinary early-stage European companies building innovative, scientific solutions to the biggest, hardest challenges of decarbonisation.

1

Freedom to Operate Publishes Open Letter to Compass Pathways Challenging Validity of Psilocybin Patent

 

[PRESSWIRE] Greenwich, Connecticut - April 14, 2022 -- The non-profit, Freedom to Operate (FTO), has just published an open letter to Compass Pathways’ CEO, George Goldsmith, regarding the invalidity of one of Compass’ U.S. patents on psilocybin.

Fobi Wins Joint Environmental Contract For District of Muskoka To Deliver AI Powered Data Solution Analyzing And Tracking Long Term Water Flow & Climate Change Impacts On Watershed

 

[PRESSWIRE] VANCOUVER, British Columbia, April 12, 2022 - Fobi AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (the “Company” or “Fobi”), a leading data intelligence company using artificial intelligence to help clients turn real-time data into actionable insights and personalized customer engagement is pleased to announce a data consulting deal to facilitate long-term tracking of land use and natural capital changes in the Muskoka watershed for the District of Muskoka, in cooperation with Dougan & Associates (“Dougan”).

1

Capital on Tap secures $200 million funding facility to fuel continued growth

 

[PRESSWIRE] ATLANTA and LONDON, 12th April 2022 – Capital on Tap has secured a $200m funding facility with HSBC and Värde Partners to support their continued US growth.